Archive →
Daily Morning Briefing

Sunday, 17 May 2026

Israel kills Hamas military chief al-Haddad, last surviving architect of 7 October · Saudi Arabia floats a Middle East non-aggression pact with Iran · G-7 finance ministers convene in Paris today as the global bond rout hits multi-decade highs · Trump–Xi summit ended with truce extension but no Taiwan, Iran or rare-earths breakthrough · UK in political limbo as Burnham clears a path to challenge Starmer
Europe/Rome 06:00 · Cash markets closed — Sunday · Inflation & sovereign-credibility repricing dominates · Week ahead: G-7 Paris Mon–Tue · China April activity Mon · FOMC minutes Wed · Nvidia Wed · Walmart Thu

Top of the morning

Markets snapshot — Friday close (cash markets closed Sat–Sun)

Levels reflect Friday 15 May 2026 close, cross-referenced from the FT homepage ticker (read live via Control Chrome on Luca's open tab) and from Bloomberg / CNBC / Yahoo Finance reporting on the session. Weekend tape; no live prints.

InstrumentLastFriday change / context
S&P 5007,408.50−1.24% · worst day since March
Nasdaq Composite26,225.14−1.54% · tech leading the slide
Dow Jones49,526.17−1.07% · −537 pts
FTSE 100−1.71% · gilts under stress
Shanghai Composite−1.02%
Nikkei 22561,409.29−2.00% · Topix −0.39% to 3,864
Hang Seng−1.6%
CSI 3004,859.59−1.12%
US 10y Treasury~4.59%+~9bp · highest since Feb 2025
US 2y Treasury~4.09%also highest since Feb 2025
UK 30y Gilt5.86% (intraday peak)highest since 1998
Japan 10y JGB~2.66%3-decade high
Brent crude (front-month)~$109.24+3.3% Friday · Hormuz week 12
WTI (front-month)~$105.66+4.4% Friday
Gold (XAU spot)~$4,530retreat from highs
EUR/USD~1.1624−0.40% on the day
GBP/USD~1.335worst week vs USD since 2024
Bitcoin~$82,000slipped on inflation fears

Geopolitics & the weekend backdrop

This weekend's signature event is the killing of Izz al-Din al-Haddad — operationally a major Israeli success, but politically a complication. He was the last senior Hamas military leader who had directly planned 7 October, and his death removes a credible interlocutor for any hostage or ceasefire arrangement. The fight inside Hamas's military structure now passes to a less experienced cohort. Parallel to that, Saudi Arabia's floated Helsinki-style non-aggression pact with Iran is the first plausible regional-architecture proposal of the post-war period — Israel will oppose it, several European capitals reportedly back it, and the Gulf producers' $15bn revenue loss since February gives Riyadh real incentive to lower the temperature. The Trump–Xi summit's closing read is "stabilisation, no thaw": truce extended, beef plants reopened, no movement on Taiwan, rare earths or a concrete Iran mechanism. Beijing's public call to reopen Hormuz remains the most macro-relevant single line if it ever translates into pressure on Tehran.

The Iran file is the operational pivot underneath everything. Twelve weeks in, the IEA's "largest oil-supply disruption in modern oil-market history" framing is now consensus; world oil demand is contracting more than 400 kb/d y-o-y; Aramco's CEO has flagged recovery slipping into 2027 even with a ceasefire today. Germany cut its 2026 growth forecast in half to 0.5% and lifted inflation to 2.7%; Chancellor Merz publicly distanced his family from US life, the cleanest signal yet of how strained Berlin–Washington has become around the Iran war and Trump's broader posture. India hiked domestic fuel prices for the first time in four years — the inflation pass-through is visible at the consumer level in major emerging economies. Russia/Ukraine: the Kyiv apartment-block strike with 24 dead, and the forensic confirmation that the Kh-101 used was built this quarter from 100+ Western components, is the year's most concrete sanctions-circumvention case study. Latvia's government collapsed over Russia-bound Ukrainian drones; Putin replaced a critic in a region bordering Ukraine.

Central banks & the rate narrative

The G-7 finance ministers and central-bank governors meet in Paris Monday and Tuesday with the global bond selloff as the unscheduled headline. Yields at multi-decade highs across all major sovereign markets, a 10-year US Treasury at 4.59% (highest since Feb 2025), a 30-year UK gilt at 5.86% intraday (highest since 1998), and a 10-year JGB near 2.66% (highest in three decades). No coordinated intervention is plausible — these moves are about fiscal trajectories and an Iran-war inflation premium, not FX dislocations — but the statement language matters. Any acknowledgement of a long-end credibility premium or sovereign-fiscal coordination would mark the moment the rates regime shift gets officially named. Silence would itself be telling. The setup is the rawest test for new Fed leadership in years; the curve is flattening into front-end repricing, and SocGen called the move "unhinged." Wednesday's FOMC minutes are the first read on the policy debate before the chair transition completes.

Outside the US the picture is one of inflation pressure building rather than easing. Russia's wartime economy shrank for the first time since 2023 — an interesting data point but not yet a constraint. Turkey scrapped its inflation target — clear central-bank credibility erosion. The Bank of England is expected to water down stablecoin rules after industry pressure, a small but symptomatic policy-bandwidth note. ECB's Stournaras flagged that a modest ECB rate move would limit economic pain — language to file ahead of the 11 June meeting, where oil upside risk is now an explicit part of the debate. The cleanest cross-region signal: the disinflation narrative the soft-landing trade depended on is under genuine strain, with German wholesale prices at a three-year high and Berlin lifting 2026 inflation to 2.7%.

Big Tech, AI & corporates — week-end positioning

The AI capital story keeps widening rather than consolidating. SpaceX is reportedly filing for IPO as soon as Wednesday at a ~$1.75tn valuation with a structure designed to ensure Musk cannot be fired — investors appear to be accepting weak shareholder rights, weak governance and a sci-fi business vision in exchange. Big Tech is going beyond Wall Street for huge AI borrowing per the FT, an obscure Japanese stock measure is widening on the global hunt for AI winners, an AI chipmaker jumped to a near-$70bn valuation in an IPO this week, and Anduril doubled its valuation to over $60bn. Multiverse hit $2.1bn in the AI-workforce-training niche. The counter-tells stay: Korea outflows accelerating despite the record rally; US job losses showing up in roles directly exposed to AI; EY retracting a study after researchers found AI hallucinations — a credibility moment for AI-augmented professional research. ASML is partnering with Tata Electronics to advance India's chip plans; OpenAI is reportedly considering legal action against Apple over the iPhone AI deal.

Around the deal and corporate tape: NextEra–Dominion at ~$400bn would create the largest US utility (the AI-power-demand thesis made concrete, announcement possible as early as Monday); Adani settled with the SEC, near-closing a multi-year US overhang on India's largest group; Schroders is exiting China mutual funds after three years; HSBC paused a $4bn private-credit allocation; and BlackRock TCP Capital valuations are being scrutinised by US prosecutors — three early cracks in the private-credit narrative worth tracking. Vodafone Idea got a $500m boost from the Birla conglomerate. Honda–Nissan tie-up speculation revived. McKinsey is cutting partner cash share in a post-AI pay revamp — the consultancy compensation model is starting to absorb AI-driven productivity gains. Berkshire sold $8bn of Chevron as oil prices soared. Starbucks said it would take a $400m charge as it cuts more corporate staff. Abu Dhabi is backing a $13bn US gas plant as Middle East supplies falter.

Health & science (worth a clinician's glance)

The Ebola outbreak in the Democratic Republic of Congo is the live infectious-disease story this weekend. The reporting frame — "testing Congo after US aid cuts" — captures the structural worry: the response capacity built up over a decade through PEPFAR-adjacent and global-health-security funding has been thinned this year, and the speed of the international response will determine whether this stays a regional containment story or becomes something larger. From a clinician's perspective the case-fatality and transmission profile of Ebola has not changed; the systems story is what's new. Worth keeping an eye on WHO situation reports through the week.

FDA news: the agency swapped its top drug and vaccine regulators as part of an internal staff overhaul — a personnel move that will affect approval pipelines, advisory-committee composition and pharmacovigilance signalling over the next quarter. Worth tracking which therapeutic areas the new appointees come from. On the AI-meets-medicine front, EY retracted a study after researchers identified AI hallucinations in the methodology — a useful prompt for the broader debate about AI-assisted literature review and citation integrity in clinical research, where the consequences of fabricated references are higher than in business consulting. Galderma reports the "Botox boom" shows no sign of sagging even as inflation hits luxury — a sector tell that dermatology aesthetics has decoupled from broader luxury cyclicality. Bloomberg also flagged Dexcom's bet beyond diabetes (sensors moving into broader wellness platforms) and Nvidia billionaire Mark Stevens's $175m gift for a new Bay Area medical school — the AI-fortunes-to-medical-philanthropy pattern is now a recognisable feature of the AI cycle.

Week ahead (CET)